Gynecomastia: Epidemiology, Pathophysiology, and Management

Samar N. Rahhal, John S. Fuqua

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Gynecomastia, defined as a palpable disk of breast tissue in males, is a relatively common condition. It is usually benign and self-resolving, especially in neonates and pubertal boys. An imbalance in the estrogen-to-androgen ratio is believed to be the culprit in the pathophysiology of gynecomastia. An increase in estrogen or a decrease in androgen is found in most pathologic entities associated with gynecomastia, such as hypogonadism, tumors, or enzymatic defects. A thorough history and physical examination is essential in distinguishing between benign and pathologic gynecomastia, as well as in directing further workup. Treatment of gynecomastia is usually for social and cosmetic reasons, and it is unnecessary in cases where it is mild or transient. However, in persistent or severe cases, treatment may be advisable. Androgens, antiestrogens, and P450 aromatase inhibitors have all been studied, with mixed results. Surgical treatment, while invasive and likely to leave scars in severe cases, is a definitive and more effective treatment option.

Original languageEnglish (US)
Title of host publicationClinical Handbook of Insomnia
EditorsHrayr Attarian
Pages189-214
Number of pages26
StatePublished - Dec 1 2010

Publication series

NameCurrent Clinical Neurology
ISSN (Print)1559-0585

Fingerprint

Gynecomastia
Epidemiology
Androgens
Estrogens
Aromatase Inhibitors
Estrogen Receptor Modulators
Hypogonadism
Therapeutics
Cosmetics
Physical Examination
Cicatrix
Breast
History
Newborn Infant
Neoplasms

Keywords

  • Adrenocortical tumors
  • Aromatase excess syndrome
  • Danazol
  • Estrogen-to-androgen ratio
  • Fibrous phase
  • Florid phase
  • Klinefelter syndrome
  • Tamoxifen
  • Testicular tumors

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Rahhal, S. N., & Fuqua, J. S. (2010). Gynecomastia: Epidemiology, Pathophysiology, and Management. In H. Attarian (Ed.), Clinical Handbook of Insomnia (pp. 189-214). (Current Clinical Neurology).

Gynecomastia : Epidemiology, Pathophysiology, and Management. / Rahhal, Samar N.; Fuqua, John S.

Clinical Handbook of Insomnia. ed. / Hrayr Attarian. 2010. p. 189-214 (Current Clinical Neurology).

Research output: Chapter in Book/Report/Conference proceedingChapter

Rahhal, SN & Fuqua, JS 2010, Gynecomastia: Epidemiology, Pathophysiology, and Management. in H Attarian (ed.), Clinical Handbook of Insomnia. Current Clinical Neurology, pp. 189-214.
Rahhal SN, Fuqua JS. Gynecomastia: Epidemiology, Pathophysiology, and Management. In Attarian H, editor, Clinical Handbook of Insomnia. 2010. p. 189-214. (Current Clinical Neurology).
Rahhal, Samar N. ; Fuqua, John S. / Gynecomastia : Epidemiology, Pathophysiology, and Management. Clinical Handbook of Insomnia. editor / Hrayr Attarian. 2010. pp. 189-214 (Current Clinical Neurology).
@inbook{9fea0d3382d546fb9e04cf257d19ebd0,
title = "Gynecomastia: Epidemiology, Pathophysiology, and Management",
abstract = "Gynecomastia, defined as a palpable disk of breast tissue in males, is a relatively common condition. It is usually benign and self-resolving, especially in neonates and pubertal boys. An imbalance in the estrogen-to-androgen ratio is believed to be the culprit in the pathophysiology of gynecomastia. An increase in estrogen or a decrease in androgen is found in most pathologic entities associated with gynecomastia, such as hypogonadism, tumors, or enzymatic defects. A thorough history and physical examination is essential in distinguishing between benign and pathologic gynecomastia, as well as in directing further workup. Treatment of gynecomastia is usually for social and cosmetic reasons, and it is unnecessary in cases where it is mild or transient. However, in persistent or severe cases, treatment may be advisable. Androgens, antiestrogens, and P450 aromatase inhibitors have all been studied, with mixed results. Surgical treatment, while invasive and likely to leave scars in severe cases, is a definitive and more effective treatment option.",
keywords = "Adrenocortical tumors, Aromatase excess syndrome, Danazol, Estrogen-to-androgen ratio, Fibrous phase, Florid phase, Klinefelter syndrome, Tamoxifen, Testicular tumors",
author = "Rahhal, {Samar N.} and Fuqua, {John S.}",
year = "2010",
month = "12",
day = "1",
language = "English (US)",
isbn = "9781603270335",
series = "Current Clinical Neurology",
pages = "189--214",
editor = "Hrayr Attarian",
booktitle = "Clinical Handbook of Insomnia",

}

TY - CHAP

T1 - Gynecomastia

T2 - Epidemiology, Pathophysiology, and Management

AU - Rahhal, Samar N.

AU - Fuqua, John S.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Gynecomastia, defined as a palpable disk of breast tissue in males, is a relatively common condition. It is usually benign and self-resolving, especially in neonates and pubertal boys. An imbalance in the estrogen-to-androgen ratio is believed to be the culprit in the pathophysiology of gynecomastia. An increase in estrogen or a decrease in androgen is found in most pathologic entities associated with gynecomastia, such as hypogonadism, tumors, or enzymatic defects. A thorough history and physical examination is essential in distinguishing between benign and pathologic gynecomastia, as well as in directing further workup. Treatment of gynecomastia is usually for social and cosmetic reasons, and it is unnecessary in cases where it is mild or transient. However, in persistent or severe cases, treatment may be advisable. Androgens, antiestrogens, and P450 aromatase inhibitors have all been studied, with mixed results. Surgical treatment, while invasive and likely to leave scars in severe cases, is a definitive and more effective treatment option.

AB - Gynecomastia, defined as a palpable disk of breast tissue in males, is a relatively common condition. It is usually benign and self-resolving, especially in neonates and pubertal boys. An imbalance in the estrogen-to-androgen ratio is believed to be the culprit in the pathophysiology of gynecomastia. An increase in estrogen or a decrease in androgen is found in most pathologic entities associated with gynecomastia, such as hypogonadism, tumors, or enzymatic defects. A thorough history and physical examination is essential in distinguishing between benign and pathologic gynecomastia, as well as in directing further workup. Treatment of gynecomastia is usually for social and cosmetic reasons, and it is unnecessary in cases where it is mild or transient. However, in persistent or severe cases, treatment may be advisable. Androgens, antiestrogens, and P450 aromatase inhibitors have all been studied, with mixed results. Surgical treatment, while invasive and likely to leave scars in severe cases, is a definitive and more effective treatment option.

KW - Adrenocortical tumors

KW - Aromatase excess syndrome

KW - Danazol

KW - Estrogen-to-androgen ratio

KW - Fibrous phase

KW - Florid phase

KW - Klinefelter syndrome

KW - Tamoxifen

KW - Testicular tumors

UR - http://www.scopus.com/inward/record.url?scp=79953658478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953658478&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:79953658478

SN - 9781603270335

T3 - Current Clinical Neurology

SP - 189

EP - 214

BT - Clinical Handbook of Insomnia

A2 - Attarian, Hrayr

ER -